Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion - CNBC

As reported by CNBC

Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.

More from Market Samachar